Structure via PubChem · Public domain (PubChem)
daledalin
Sign in to saveAlso known as UK-3557-15
Daledalin (UK-3557-15) is an antidepressant which was synthesized and trialed for depression in the early 1970s, but was never marketed. It is a selective norepinephrine reuptake inhibitor, with no significant effects on the reuptake of serotonin and dopamine, and no antihistamine or anticholinergic properties.
In the Vinony graph
Within Vinony's link graph, daledalin is referenced by 897 other articles, and connects out to histamine antagonist, tetracyclic antidepressant and adrenergic uptake inhibitors.
It is catalogued under topics including Abandoned drugs, Antidepressants and Chemical pages without DrugBank identifier.
Its subject is documented across 5 Wikipedia language editions.
Chemical data
- Formula
- C19H24N2
- Molecular weight
- 280.4 g/mol
- IUPAC name
- N-methyl-3-(3-methyl-1-phenyl-2H-indol-3-yl)propan-1-amine
- SMILES
- CC1(CN(C2=CC=CC=C21)C3=CC=CC=C3)CCCNC
- InChIKey
- YFAIJBZEDDOCAN-UHFFFAOYSA-N
- XLogP
- 4.3
- Polar surface area
- 15.3 Ų
- H-bond donors
- 1
- H-bond acceptors
- 2
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 280.193949
Show 3 more facts
- chemical formula
- C₁₉H₂₄N₂
- canonical SMILES
- CC1(CN(C2=CC=CC=C21)C3=CC=CC=C3)CCCNC
- Commons category
- Daledalin
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- Synthesis
- References
Daledalin (UK-3557-15) is an antidepressant which was synthesized and trialed for depression in the early 1970s, but was never marketed. It is a selective norepinephrine reuptake inhibitor, with no significant effects on the reuptake of serotonin and dopamine, and no antihistamine or anticholinergic properties.
==Synthesis== Daledalin can be prepared by the reduction of amedalin with diborane. thumb|left|500px|class=skin-invert-image|Daledalin synthesis
Excerpted from Wikipedia’s “daledalin” article, available under the CC BY-SA 4.0 licence.